Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

JB Chemicals & Pharmaceuticals Ltd.

http://www.jbcpl.com

Latest From JB Chemicals & Pharmaceuticals Ltd.

India Proposes Faster Approvals, Bayh-Dole-Like Policy To Spur Innovation

India’s draft policy to catalyze R&D and innovation seeks to create a “regulatory bias” towards innovation and aims to cut approval timelines sharply, among a raft of other proposals that include enabling differential pricing for “innovation with therapeutic benefits.” The Pink Sheet explores multiple nuances of the plan with industry experts.

Policy India

Who’s Hired? Another Viatris Executive Joins Neuraxpharm

Neuraxpharm has appoints Viatris’ head of finance in Germany as its new commercial central region officer and country manager to strengthen its position in the German market, while Stada has hired a new head of consumer health in Germany. Meanwhile, the AAM has made multiple key appointments and Hyloris, Siegfried and Mayne Pharma have made top-level additions.

BioPharmaceutical Strategy

Who’s Hired? BIO’s Duncan Joins AAM

The Association for Accessible Medicines has appointed former Biotechnology Innovation Organization representative Joanne Duncan as its new chief operating officer.  Meanwhile, Coherus has names the new chair of its scientific advisory board, while women’s health specialist Theramex has added to its board of directors

International Executive Changes

JB Chemicals Strong Run Of Growth Continues With International Rise

JB Chemicals posted yet another strong quarter of growth to cap off its 2021 financial year, with broad revenue increases and a focus on ‘cost excellence’ leading to increased profit margins.   

Sales & Earnings Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Contract Manufacturing Organization
  • Other Names / Subsidiaries
    • Unique Pharmaceutical Laboratories
UsernamePublicRestriction

Register